We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · November 05, 2020

Venetoclax With Azacitidine or Decitabine in Patients With Newly Diagnosed Acute Myeloid Leukemia

American Journal of Hematology

 

Additional Info

Disclosure statements are available on the authors' profiles:

American Journal of Hematology
Venetoclax With Azacitidine or Decitabine in Patients With Newly Diagnosed Acute Myeloid Leukemia: Long Term Follow-Up From a Phase 1b Study
Am. J. Hematol 2020 Oct 29;[EPub Ahead of Print], DA Pollyea, K Pratz, A Letai, BA Jonas, AH Wei, V Pullarkat, M Konopleva, MJ Thirman, M Arellano, PS Becker, B Chyla, WJ Hong, Q Jiang, J Potluri, CD DiNardo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading